STIDEX PBC – Trademark Portfolio
Entity Type: 03
STIDEX PBC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include STIDEX STRATEGIC INVESTMENTS DIVERSIFIED EXPANSION. The owner is based in san Jose, CA.
san Jose, CA 951265006
Showing of trademarks Trademarks
Trademark Classifications
STIDEX PBC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does STIDEX PBC have?
STIDEX PBC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.
What trademark classes does STIDEX PBC file in?
STIDEX PBC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are STIDEX PBC's most well-known trademarks?
STIDEX PBC's registered trademark portfolio includes well-known marks such as STIDEX STRATEGIC INVESTMENTS DIVERSIFIED EXPANSION. These are among 1 currently registered trademark in the portfolio.
What is STIDEX PBC's trademark registration success rate?
STIDEX PBC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.